Consent to the Distribution of Changed Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act, and are set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Fluticasone propionate 125 mcg, 250 mcg per actuation Spray, oral, metered dose Glaxo Wellcome Operations, Speke, Liverpool, United Kingdom and Laboratoire Glaxo Wellcome, Evreux, France Flixotide Paracetamol 24 mg/mL, 50 mg/mL in 2L Suspension, oral Douglas Pharmaceuticals Limited, Mount Wellington, Auckland Paracetamol Paracetamol 24 mg/mL, 50 mg/mL in 100 mL, 200 mL Suspension, oral Douglas Pharmaceuticals Limited, Mount Wellington, Auckland Paracetamol (Pharmacycare) Ramipril 1.25 mg, 2.5 mg, 5 mg, 10 mg Tablets Hoechst AG., Frankfurt (Main), Germany Tritace Didanosine 25 mg, 50 mg, 100 mg, 150 mg Tablets, chewable/ dispersible Bristol-Myers Squibb Co, Evansville, Indianna, United States of America Videx (mandarin orange flavour) Dated this 11th day of July 1997. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on 20 February 1997.